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Background
We have previously developed an innovative vaccine
based on the genetic mutability and diversity of variable
HIV-1 epitopes. This polyvalent peptide vaccine has been
shown to induce a broadly reactive peripheral immune
response in mice and macaques (Azizi A, J. Immunol,
2008). Our group recently developed a lipid-based vesicle
as an oral vaccine delivery system for the induction of
mucosal immunity within mucosal tissues. In this study,
we take advantage of this technology to entrap our HIV-1
vaccine into this lipid-based vesicle. We then evaluated
the ability of our vaccine formulations to induce matura-
tion of mouse dendritic cells. In vitro experiments have
shown our liposomally-delivered candidate vaccine to be
effective in inducing the maturation of mouse dendritic
cells, as demonstrated by increased cell surface MHCII
and CD86 expression.
Methods
Mice were sacrificed and bone marrow from femur, tibia
and humerus was collected. Marrow cells were then cul-
tured in the presence of IL-4 and GM-CSF for 5 days
before being loaded with antigen to induce maturation.
The presence of cell surface markers related to dendritic
cell maturation was then evaluated by flow cytometry.
Results
Stimulation of immature bone marrow-derived murine
dendritic cells with liposomally-delivered HIV peptides
induces maturation of these cells, as determined by
increased expression of cell-surface markers MHCII and
CD86.
Conclusion
Our data indicate that the incorporation of multiple HIV-
1 epitopes into a lipid-based delivery system is effective in
inducing the maturation of murine dendritic cells. Our
findings suggest that a liposomal-based delivery system
may act as an effective delivery vehicle.
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